Malformations Following Methimazole Exposure In Utero: An Open Issue

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 12, 2003, Pages 989-992

  Ferraris, Silvio ^a   Valenzise, Mariella ^a   Lerone, Margherita ^b   Divizia, Maria Teresa ^b   Rosaia, Lucia ^b   Blaid, Dario ^b   Nemelka, Odette ^b   Ferrero, Giovanni Battista ^a   Silengol, Margherita ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Aplasia cutis; Methimazole embryopathy; Thyroid

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE;

ARTICLE; CASE REPORT; CONGENITAL MALFORMATION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EMBRYOTOXICITY; FEMALE; FETOTOXICITY; FETUS DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NEWBORN; NEWBORN DISEASE; PLACENTAL TRANSFER; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ANTITHYROID AGENTS; ECTODERMAL DYSPLASIA; FEMALE; HUMANS; HYPERTHYROIDISM; INFANT, NEWBORN; MALE; MATERNAL AGE; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; SCALP; TWINS;

EID: 0347623326     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10098     Document Type: Article

References (25)

1. Barwell J, Fox GF, Round J, Berg J. 2002. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole? Am J Med Genet 111:55-56.
2. Bihan H, Vazquez MP, Krivitky A. 2002. Aplasia cutis congenita and dysmorphic syndrome after antithyroid therapy during pregnancy. Endocrinologist 12:87-91.
3. Clementi M, Di Gianantonio E, Pelo E, et al. 1999. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43-46.
4. Diav-Citrin O, Ornoy A. 2002. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 65:38-44.
5. Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. 2001. Adverse effects of prenatal methimazole exposure. Teratology 64:262-266.
6. Easterling TR, Schmucker BC, Carlson KL, et al. 1991. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol 78:348-352.
7. Greenberg F. 1987. Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Am J Med Genet 28:931-934.
8. Hollingsworth DR. 1983. Graves' disease. Clin Obstet Gynecol 26:615-634.
9. Johnsson E, Larsson G, Ljunggren M. 1997. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 350:1520.
10. Marchant B, Brownlie BEW, McKay Hart D, et al. 1977. The placental transfer of propylthiouracil, methimazole and carbirnazole. J Clin Endocrinol Metab 45:1187-1193.
11. Martin-Denavit T, Edery P, Plauchu H, et al. 2000. Ectodermal abnormalities associated with methimazole intrauterine exposure. Am J Med Genet 94:338-340.
12. Milham S, Elledge W. 1972. Maternal methimazole and congenital defects in children (letter). Teratology 5:125.
13. Millar LK, Wing DA, Leung AS, et al. 1994. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946-949.
14. Mitsuda N, Tamaki H, Amino N, et al. 1992. Risk factors for developmental disorders in infants born to women with Graves disease. Obst Gynecol 80:359-364.
15. Momotami N, Ito K, Hamada N, et al. 1984. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 20:695-700.
16. Mortimer RH, Cannel GR, Addison RS, et al. 1997. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82:3099-3102.
17. Porreco RP, Bloch CA. 1990. Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol 76:509-512.
18. Rodriguez-Garcia R. 1999. Bilateral renal agenesis (Potter's syndrome) in a girl born to a hyperthyroid mother who received methimazole in early pregnancy. Ginecol Obtet Mex 67:587-589.
19. Roti E, Minelli R, Salvi M. 1966. Management of hyperthyroidism and hypothyroidism in pregnant woman. J Clin Endocrinol Metab 81:1679-1682.
20. Shepard TH, Brent RL, Friedman JM, et al. 2002. Update on new developments in the study of human teratogens. Teratology 65:153-161.
21. Sugrue D, Drury MI. 1980. Hyperthyroidism complicating pregnancy: result of treatment by antithyroid drug in 77 pregnancies. Br J Obstet Gynaecol 87:970-975.
22. Treadwell MC, Sherer DH, Saccks AJ, et al. 1996. Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism. Obstet Gynecol 87:838-840.
23. Wilson LC, Kerr BA, Wilkinson R, et al. 1998. Choanal atresia and hypothelia following methimazole exposuire in utero: a second report. Am J Med Genet 75:220-222.
24. Wing DA, Millar LK, Koonings PP, et al. 1994. A comparison of propylthiouracil versus methimazole in treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170:90-95.
25. Zimmerman D. 1999. Fetal and neonatal hyperthyroidism. Thyroid 9:727-733.